4.7 Article

Intravesical Pseudomonas aeruginosa mannose-sensitive Hemagglutinin vaccine triggers a tumor-preventing immune environment in an orthotopic mouse bladder cancer model

Related references

Note: Only part of the references are listed.
Article Oncology

Effect of HLA genotype on intravesical recurrence after bacillus Calmette-Guerin therapy for non-muscle-invasive bladder cancer

Mizuki Kobayashi et al.

Summary: This study demonstrates the impact of HLA gene polymorphism and specificity on intravesical recurrence after BCG therapy in NMIBC patients, highlighting the importance of HLA-B loci diversity.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)

Article Immunology

Immunological Hallmarks for Clinical Response to BCG in Bladder Cancer

Chun Jye Lim et al.

Summary: This study identified immune subset changes and gene expression features associated with BCG treatment by analyzing patient blood and tissue samples. It also found that baseline densities of non-Treg and CD8(+)PD-1(+) T cells were predictive of response and recurrence-free survival after BCG. Furthermore, the study revealed predictive biomarkers for response and resistance mechanisms to BCG.

FRONTIERS IN IMMUNOLOGY (2021)

Article Multidisciplinary Sciences

Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer

Amelie Cachot et al.

Summary: CD4 T cells displaying cytotoxic phenotypes were identified in different human cancers through mining single-cell RNA-seq datasets. Ex vivo confirmation of the cytolytic tumor-specific CD4 T cells was achieved using peptide-MHCII-multimer technology. The cytotoxic activity of these cells, partially dependent on SLAMF7, was demonstrated to have delayed kinetics compared to classical cytotoxic lymphocytes, and agonistic engagement of SLAMF7 enhanced their cytotoxicity, indicating potential synergy with other cancer immunotherapies.

SCIENCE ADVANCES (2021)

Article Urology & Nephrology

100 years of Bacillus Calmette-Guerin immunotherapy: from cattle to COVID-19

Niyati Lobo et al.

Summary: Bacillus Calmette-Guerin (BCG) has been widely used for 100 years to prevent tuberculosis, and it also stimulates an anti-tumour immune response. The non-specific effects of BCG, which occur via the induction of trained immunity, have led to the hypothesis that BCG vaccination could protect against the severity of COVID-19.

NATURE REVIEWS UROLOGY (2021)

Article Biochemistry & Molecular Biology

Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer

David Y. Oh et al.

Article Multidisciplinary Sciences

Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-γ signaling

Anthony C. Antonelli et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Immunology

Macrophages as regulators of tumour immunity and immunotherapy

David G. DeNardo et al.

NATURE REVIEWS IMMUNOLOGY (2019)

Article Biochemistry & Molecular Biology

Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer

Suk Hyung Lee et al.

Review Urology & Nephrology

Mechanisms of BCG immunotherapy and its outlook for bladder cancer

Caroline Pettenati et al.

NATURE REVIEWS UROLOGY (2018)

Review Immunology

Developmental and Functional Heterogeneity of Monocytes

Martin Guilliams et al.

IMMUNITY (2018)

Review Urology & Nephrology

BCG-unresponsive non-muscle invasive bladder cancer: recommendations from the IBCG

Ashish M. Kamat et al.

NATURE REVIEWS UROLOGY (2017)

Review Immunology

Dendritic cells in cancer: the role revisited

Filippo Veglia et al.

CURRENT OPINION IN IMMUNOLOGY (2017)

Review Immunology

The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment

Vinit Kumar et al.

TRENDS IN IMMUNOLOGY (2016)

Article Urology & Nephrology

Nonpathogenic Mycobacterium brumae Inhibits Bladder Cancer Growth In Vitro, Ex Vivo, and In Vivo

Estela Noguera-Ortega et al.

EUROPEAN UROLOGY FOCUS (2016)

Review Oncology

Modelling bladder cancer in mice: opportunities and challenges

Takashi Kobayashi et al.

NATURE REVIEWS CANCER (2015)

Review Urology & Nephrology

The mechanism of action of BCG therapy for bladder cancer-a current perspective

Gil Redelman-Sidi et al.

NATURE REVIEWS UROLOGY (2014)

Review Oncology

History of myeloid-derived suppressor cells

James E. Talmadge et al.

NATURE REVIEWS CANCER (2013)

Article Cell Biology

Preexisting BCG-Specific T Cells Improve Intravesical Immunotherapy for Bladder Cancer

Claire Biot et al.

SCIENCE TRANSLATIONAL MEDICINE (2012)

Article Urology & Nephrology

Laparoscopic radical cystectomy with orthotopic ileal neobladder: A report of 85 cases

Jian Huang et al.

JOURNAL OF ENDOUROLOGY (2008)